Cargando…
Evaluating the effect of Roxadustat on ventricular repolarization in patients undergoing peritoneal dialysis
BACKGROUND: Roxadustat is a novel oral medication used to treat anemia in CKD patients. Several studies have shown that Roxadustat can alleviate anemia in CKD patients by increasing hemoglobin levels and regulating iron metabolism. We aimed to evaluate the effect of Roxadustat on ventricular repolar...
Autores principales: | Zhang, Yangyang, Zhang, Liang, Ge, Pengcheng, Xu, Ruyi, Ye, Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566199/ https://www.ncbi.nlm.nih.gov/pubmed/37821963 http://dx.doi.org/10.1186/s40001-023-01368-0 |
Ejemplares similares
-
Effects of Roxadustat on the Anemia and Iron Metabolism of Patients Undergoing Peritoneal Dialysis
por: Hirai, Keiji, et al.
Publicado: (2021) -
Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia
por: Zhu, Xin-Wang, et al.
Publicado: (2021) -
Efficacy of Roxadustat on anemia and residual renal function in patients new to peritoneal dialysis
por: Wu, Tong, et al.
Publicado: (2022) -
Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study
por: Zhang, Xuejie, et al.
Publicado: (2023) -
Comparison of risk of peritoneal dialysis-associated peritonitis between roxadustat and recombinant human erythropoietin in peritoneal dialysis patients: a retrospective comparative cohort study
por: Zhang, Wei, et al.
Publicado: (2022)